Vaccines, blood, antisera, toxins and cultures in Brazil | The Observatory of Economic Complexity

About

Exports In 2022, Brazil exported $310M in Vaccines, blood, antisera, toxins and cultures, making it the 30th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 102nd most exported product in Brazil. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Brazil are: China ($151M), Uruguay ($21.4M), United Kingdom ($19.9M), Germany ($9.72M), and Paraguay ($7.9M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Brazil between 2021 and 2022 were China ($149M), Uruguay ($14.7M), and Japan ($7.62M).

Imports In 2022, Brazil imported $4.71B in Vaccines, blood, antisera, toxins and cultures, becoming the 16th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Brazil. Brazil imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($1.11B), Switzerland ($717M), United States ($702M), Germany ($526M), and Ireland ($336M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Brazil between 2021 and 2022 were Germany ($344M), Belgium ($318M), and Argentina ($150M).

COMPANIES In 2023, leading companies such as DOLE FRESH FRUIT COMPANY (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Brazil to the United States.

Latest Trends

March 2024

About

Overview In March 2024 Brazil's Vaccines, blood, antisera, toxins and cultures exports accounted up to $8.87M and imports accounted up to $554M, resulting in a negative trade balance of $545M. Between March 2023 and March 2024 the exports of Brazil's Vaccines, blood, antisera, toxins and cultures have decreased by $-8.13M (-47.8%) from $17M to $8.87M, while imports decreased by $-134M (-19.4%) from $688M to $554M.

Destinations In March 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United Kingdom ($3.09M), Nigeria ($1.28M), France ($800k), India ($474k), and Estonia ($406k), and were imported mostly from Germany ($111M), Switzerland ($79M), Puerto Rico ($69.7M), Ireland ($59.8M), and United States ($42.6M).

Growth In March 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to Germany ($-6.35M or -99.6%), United States ($-6.32M or -98.2%), and Hong Kong ($-500k or -99.8%). In March 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from China ($-173M or -98.5%), United States ($-23.8M or -42.9%), and South Korea ($-9.73M or -48.8%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (March 2023 - March 2024)$-8.13M(-47.8%)

IMPORT GROWTH (March 2023 - March 2024)$-134M(-19.4%)

MAIN EXPORTER (March 2024)São Paulo$4.79M

MAIN DESTINATION (March 2024)United Kingdom$3.09M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Brazil. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download